Menu ×


Polycystic Ovary Syndrome Treatment Market Segmentation By Drugs (Oral Contraceptives, Insulin-Sensitizing Drugs, Antidepressants, Anti-Androgen Drugs and Others); By Surgery (Laparoscopic Ovarian Drilling and Ovarian Wedge Resection); By Distribution Channel (Online and Offline) – Global Demand Analysis & Opportunity Outlook 2027

  • Text Size:

Extensive insights into the Growth of Polycystic Ovary Syndrome Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More


In April 2017, Millendo Therapeutics, Inc., a biopharmaceutical company in its clinical stage, announced the publication of positive data which came from a Phase 2 clinical trial of MLE4901, which was used for the treatment of menopausal vasomotor symptoms (VMS) which affect a large majority of menopausal women. In addition to this, the company planned to continue the Phase 2b clinical program of MLE4901 for polycystic ovary syndrome (PCOS).

Introduction to Polycystic Ovary Syndrome

Polycystic ovary syndrome is a hormonal condition in women characterized by the formation of multiple cysts in the ovaries. PCOS particularly occurs among women who are of the reproductive age. These cysts might obstruct the process of ovulation and lead to infertility among the affected women. Currently, no specific drug for the treatment of PCOS is available in the market. However, various drugs that control the hormones in the body can be used in order to restrict any further cyst growths in the ovary.

Market Size and Forecast

The polycystic ovary syndrome treatment market is anticipated to record a CAGR of around 5% over the forecast period, i.e., 2019-2027. The market is segmented by drugs, by surgery, by distribution channel and by region, out of which, the drugs segment is further segmented into oral contraceptives, insulin-sensitizing drugs, antidepressants, anti-androgen drugs and others. Based on drugs, the insulin-sensitizing drugs is anticipated to hold the largest share in the polycystic ovary syndrome treatment market on account of higher demand of anti-diabetic drugs that decrease the hormone levels, thereby controlling PCOS as well as diabetes. Since androgens are secreted in excess in this disorder, the levels of insulin in the body are affected which eventually leads to diabetes. Further, insulin-sensitizing drugs prevent the onset of diabetes that might result from PCOS which is further estimated to raise the demand for this segment. The oral contraceptives segment is estimated to grow at the highest rate as a result of easy availability of these medications at online and offline pharmacies. Contraceptives are used in order to treat the common symptoms of PCOS such as to provide relief from menstrual pain and treat irregular menstrual cycles, which is further anticipated to raise the demand for this segment in the upcoming years.

Polycystic Ovary Syndrome Treatment Market Graph

Growth Drivers

Growing Awareness among Women about the Risks of PCOS to Drive the Market Growth

The various risks to the health of women, especially to the reproductive health, that result from polycystic ovary syndrome are increasing the awareness among women for the prevention of this disorder. PCOS is a common cause of infertility among women, affecting about 6% to 12% of females, i.e., around 5 million women in the United States, as reported by Centers for Disease Control and Prevention. The rising understanding about PCOS results in a greater knowledge and better diagnosis of the symptoms of this disorder including irregular or no menstruation, excessive growth of hair, weight gain, acne and irregular ovulation.CLICK TO DOWNLOAD SAMPLE REPORT

Reducing the Risk of Disorders Linked with PCOS to Boost the Market Growth

PCOS leads to the development of various disorders including diabetes, heart diseases and several other hormone related disorders. The serious health disorders linked with polycystic ovary syndrome result in a greater requirement for the elimination of this disorder, which is estimated to significantly propel the market growth.


Lack of Availability of Proper Medication to Hamper the Market Growth

As there is no known cause of polycystic ovary syndrome, the drugs available for the treatment are not highly accurate. Moreover, the drugs change the hormone levels in the body which further increases the side effects including body weight gain or loss, irregular menstruation, bloating and others. These factors are estimated to hinder the growth of PCOS treatment market over the forecast period.

Market Segmentation

Our in-depth analysis of the polycystic ovary syndrome treatment market includes the following segments:

By Drugs

  • Oral Contraceptives
  • Insulin-Sensitizing Drugs
  • Antidepressants
  • Anti-Androgen Drugs 
  • Others

By Surgery

  • Laparoscopic Ovarian Drilling
  • Ovarian Wedge Resection

By Distribution Channel

  • Online
  • Offline

By Region

On the basis of regional analysis, the polycystic ovary syndrome treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

The largest share in the polycystic ovary syndrome market is anticipated to be held by the market in North America on account of higher number of cases of PCOS diagnosed in the region. Moreover, the incidence of this disorder among women was reported to be higher as a result of better medical facilities and increasing awareness among women. The presence of key players in the market in this region is an additional factor estimated to contribute towards the market growth. The market in Asia Pacific, however, is anticipated to observe the highest rate of growth during the forecast period on account of greater population that gives rise to more cases of polycystic ovary syndrome, mainly in regions of China and India.

The polycystic ovary syndrome treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating the Market

  • Millendo Therapeutics, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Bayer AG
  • Ferring B.V.
  • Novartis AG
  • EffRx Pharmaceuticals SA
  • Bristol-Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline
  • Mylan N.V.
  • Sanofi S.A.

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved